Naga Chalasani News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AGA Reading Room | Archita Desai on a New Tool to Monitor Cirrhosis Patients

Liver cirrhosis imposes a growing economic burden on the U.S. .

United statesUniversity of arizonaClin gastroenterol hepatolNaga chalasaniMichael fallonArchitap desaiIndiana universityNational institute of diabetesIndiana university school of medicineNational institutes of healthIndiana university schoolClinical gastroenterologyReading roomCirrhosis coachAmerican associationLiver disease career development award

Zydus announces EPICS-III™ Phase 2(b)/3 adaptive pivotal clinical trial of Saroglitazar Mg in PBC

Zydus announces EPICS-III™ Phase 2(b)/3 adaptive pivotal clinical trial of Saroglitazar Mg in PBC
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.

United statesNaga chalasaniPankajr patelUs food drug administrationEuropean medicines agencyCadila healthcare ltdDepartment of medicineCadila healthcareTime zoneSaroglitazar magnesiumSubjects with primary biliary cholangitisAlkaline phosphatasePatient global impressionPatient global therapeutic benefitWorst itch severityInterim chair

Zydus receives US FDA approval to initiate Phase 2(b)/3 on liver disease

The positive results from the Phase 2(a) Clinical Trial Evaluating Saroglitazar Mg in patients with NASH were published in the Journal of Hepatology

Naga chalasaniDepartment of medicineSaroglitazar magnesiumSubjects with primary biliary cholangitisAlkaline phosphataseProf naga chalasaniInterim chairIndiana university schoolS fdaLiver disease

UPDATE – Galectin Therapeutics to Present Six Scientific

New data regarding the mechanism of action of belapectin to inhibit galectin-3Unique pharmacokinetic profile of belapectin in patients with hepatic.

Naga chalasaniEric lawitzAndrea mladenovicArchita parikh desaiStephena harrisonD harold shlevinRaj vuppalanchiPol boudesBarbara lomeliHarold shlevinNagap chalasaniZachary goodmanEliezer zomerKhim chngJuan rondonMazen noureddin

Novel Blood-Based Panel Highly Effective for Early-Stage HCC

A test like this could help enhance guideline-recommended surveillance methods used for at-risk patients.

United statesNaga chalasaniIndiana universityClinical gastroenterologyEuropean associationAmerican associationLiver diseasesHepatocellular carcinomaLiver cancerHepatocellular cancerAncer liverAncer hepatocellularIological markerLiver diseaseBiliary diseaseAllbladder disease